Ovarian cancers screening endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Endometrium Tumor Cells, Cultured Neoplastic Stem Cells Ovary Epithelial Cells Breast

Organisms2

Mice, Nude Mice, SCID

Diseases68

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Carcinoma, Endometrioid Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Breast Neoplasms Neoplasm Invasiveness Neoplasms Pancreatic Neoplasms Carcinoma Lung Neoplasms Adenocarcinoma, Clear Cell Prostatic Neoplasms Neoplasm Metastasis Genetic Predisposition to Disease Colonic Neoplasms Uterine Neoplasms Endometrial Hyperplasia Stomach Neoplasms Adenocarcinoma Adenocarcinoma, Mucinous Genital Neoplasms, Female Neoplasm Recurrence, Local Neoplasms, Multiple Primary Neoplasms, Cystic, Mucinous, and Serous Uterine Cervical Neoplasms Peritoneal Neoplasms Disease Progression Neoplasms, Second Primary Colorectal Neoplasms Cystadenocarcinoma, Papillary Colorectal Neoplasms, Hereditary Nonpolyposis Urinary Bladder Neoplasms Skin Neoplasms Adenocarcinoma, Papillary Carcinoma, Squamous Cell Cell Transformation, Neoplastic Cystadenocarcinoma Liver Neoplasms Ascites Carcinoma, Non-Small-Cell Lung Neoplasms, Hormone-Dependent Rectal Neoplasms Thyroid Neoplasms Kidney Neoplasms Precancerous Conditions Neovascularization, Pathologic Neoplasms, Radiation-Induced Gastrointestinal Neoplasms Cystadenocarcinoma, Mucinous Carcinoma, Papillary Bone Neoplasms Mouth Neoplasms Esophageal Neoplasms Neoplasms, Experimental Neoplastic Syndromes, Hereditary Head and Neck Neoplasms Mixed Tumor, Mullerian Fallopian Tube Neoplasms Microsatellite Instability Cystadenoma, Serous Testicular Neoplasms Carcinoma, Pancreatic Ductal Adenoma Cystadenoma Carcinoma, Small Cell Vaginal Neoplasms

Chemicals and Drugs51

CA-125 Antigen Tumor Markers, Biological Neoplasm Proteins Antineoplastic Agents DNA, Neoplasm Paclitaxel Cisplatin Tamoxifen RNA, Messenger Estrogens Receptors, Estrogen Receptors, Progesterone Cancer Vaccines BRCA2 Protein Antigens, Neoplasm Antineoplastic Agents, Hormonal RNA, Small Interfering BRCA1 Protein Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Receptor, erbB-2 Epididymal Secretory Proteins Progestins Contraceptives, Oral Carboplatin Tumor Suppressor Proteins RNA, Neoplasm PTEN Phosphohydrolase Nuclear Proteins Antibodies, Monoclonal DNA-Binding Proteins MicroRNAs Estrogen Receptor alpha Estrogen Antagonists Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins Transcription Factors Anticarcinogenic Agents Receptor, Epidermal Growth Factor Prostate-Specific Antigen Antigens, Tumor-Associated, Carbohydrate Fluorouracil Adaptor Proteins, Signal Transducing Estrogen Receptor Modulators Selective Estrogen Receptor Modulators MutS Homolog 2 Protein Taxoids Ki-67 Antigen Platinum Deoxycytidine Receptors, Androgen

Analytical, Diagnostic and Therapeutic Techniques and Equipment66

Early Detection of Cancer Neoplasm Staging Prognosis Risk Factors Risk Survival Analysis Survival Rate Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Hysterectomy Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Xenograft Model Antitumor Assays Prospective Studies Odds Ratio Follow-Up Studies Gene Expression Profiling Disease-Free Survival Risk Assessment Registries Blotting, Western Neoplasm Transplantation Neoplasm Grading Incidence Sensitivity and Specificity Salpingectomy Kaplan-Meier Estimate Oligonucleotide Array Sequence Analysis Combined Modality Therapy Cohort Studies Multivariate Analysis Genetic Testing Transplantation, Heterologous Polymerase Chain Reaction Estrogen Replacement Therapy Logistic Models Treatment Outcome Tissue Array Analysis SEER Program Chemotherapy, Adjuvant Drug Screening Assays, Antitumor Immunoenzyme Techniques Confidence Intervals Questionnaires Molecular Targeted Therapy Tumor Burden Predictive Value of Tests Transfection DNA Mutational Analysis Lymph Node Excision Clinical Trials as Topic Reproducibility of Results Neoplasms, Experimental Gene Knockdown Techniques Body Mass Index Drug Administration Schedule Flow Cytometry Hormone Replacement Therapy Radiotherapy, Adjuvant Radiotherapy Gynecologic Surgical Procedures Reproductive History Biopsy Mammography Models, Biological

Psychiatry and Psychology1

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Genes, BRCA1 Drug Resistance, Neoplasm Risk Mutation Odds Ratio Germ-Line Mutation Cell Proliferation Postmenopause Genes, BRCA2 DNA Methylation Apoptosis Genotype Sensitivity and Specificity Cell Survival Cell Growth Processes Polymorphism, Genetic Gene Silencing Down-Regulation Cell Division Genes, Tumor Suppressor Cell Movement Signal Transduction Cell Cycle Menopause Dose-Response Relationship, Drug Promoter Regions, Genetic Up-Regulation Transfection RNA Interference Parity Premenopause Genes, Neoplasm Base Sequence Gene Expression Microsatellite Repeats Body Mass Index Alleles Time Factors Diet Genes, p53 Heterozygote Microsatellite Instability Loss of Heterozygosity Drug Synergism Phenotype Phosphorylation Epithelial-Mesenchymal Transition Gene Amplification

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Survival

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care32

Risk Factors Risk Survival Analysis Survival Rate Case-Control Studies Retrospective Studies Prospective Studies Odds Ratio Follow-Up Studies Disease-Free Survival Risk Assessment Registries Age Factors Incidence Sensitivity and Specificity Kaplan-Meier Estimate Cohort Studies Multivariate Analysis Genetic Testing Logistic Models Treatment Outcome SEER Program Confidence Intervals National Cancer Institute (U.S.)Questionnaires Predictive Value of Tests Parity Clinical Trials as Topic Reproducibility of Results Body Mass Index Reproductive History Confounding Factors (Epidemiology)

Geographicals4

United States Sweden China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Carcinoma, Endometrioid Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Early Detection of Cancer Breast Neoplasms Neoplasm Invasiveness Cell Line, Tumor Neoplasm Staging Neoplasms Gene Expression Regulation, Neoplastic CA-125 Antigen Pancreatic Neoplasms Carcinoma Tumor Markers, Biological Prognosis Lung Neoplasms Neoplasm Proteins Adenocarcinoma, Clear Cell Mice, Nude Prostatic Neoplasms Neoplasm Metastasis Risk Factors Genetic Predisposition to Disease Genes, BRCA1 Antineoplastic Agents Drug Resistance, Neoplasm Risk Colonic Neoplasms Uterine Neoplasms Survival Analysis Endometrial Hyperplasia Stomach Neoplasms Survival Rate Adenocarcinoma Adenocarcinoma, Mucinous Genital Neoplasms, Female DNA, Neoplasm Immunohistochemistry Neoplasm Recurrence, Local Reverse Transcriptase Polymerase Chain Reaction Hysterectomy Case-Control Studies Paclitaxel Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Cisplatin Mutation Xenograft Model Antitumor Assays Prospective Studies Tamoxifen Odds Ratio Neoplasms, Multiple Primary Neoplasms, Cystic, Mucinous, and Serous Germ-Line Mutation Follow-Up Studies RNA, Messenger Uterine Cervical Neoplasms Peritoneal Neoplasms Disease Progression Endometrium Gene Expression Profiling Cell Proliferation Disease-Free Survival Postmenopause Neoplasms, Second Primary Estrogens Receptors, Estrogen Colorectal Neoplasms Risk Assessment Genes, BRCA2 Registries Receptors, Progesterone Tumor Cells, Cultured DNA Methylation Cancer Vaccines Blotting, Western Neoplasm Transplantation BRCA2 Protein United States Antigens, Neoplasm Cystadenocarcinoma, Papillary Apoptosis Neoplasm Grading Antineoplastic Agents, Hormonal Age Factors Genotype Colorectal Neoplasms, Hereditary Nonpolyposis Incidence RNA, Small Interfering BRCA1 Protein Sensitivity and Specificity Urinary Bladder Neoplasms Salpingectomy Antineoplastic Agents, Phytogenic Skin Neoplasms Adenocarcinoma, Papillary Carcinoma, Squamous Cell

No FAQ available that match "ovarian cancers screening endometrial cancer vulvar neoplasms"